We need more empirical studies about the impact of generative AI on our mental health. I dissect one recent study to show counterintuitive results. An AI Insider scoop.

Methods: For this systematic review and meta-analysis, we searched 6 electronic databases (PsycINFO, Embase, MEDLINE, PSYNDEX, PubMed, and Web of Science) for randomized controlled trials ...

You want that new video game so badly, but you’re trying to knock your credit card balance down. Or you’re binging your favorite TV show and can’t wait to find out if a character lives, but it’s late, ...

Abstract: Safety and data efficiency are important concerns in data-driven control, especially for nonlinear systems with unknown dynamics and subject to disturbances. In this work, we consider a ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.25 years, SD 9.46 years) recently diagnosed with T2D.

The impact of intensive blood pressure (BP) control on cognitive function in East Asian populations remains uncertain. We aimed to assess the effect of a lower systolic BP target on global cognitive ...

Average current-mode control, as shown in Figure 1, is common in continuous-conduction-mode (CCM) power factor correction (PFC). It has two loops: a voltage loop that works as an outer loop and a ...

This 40sqm cabin, known as The Pod, is designed as a complete living system. Every function — sleeping, cooking, working — is integrated with precision. Instead of space, the design prioritizes ...

A new study in the American Journal of Preventive Medicine reports findings from a randomized controlled trial—the gold standard study design in health research—showing that promoting drinking water ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...